Unbuzzd Wellness names Richard Buzbuzian CEO for US expansion

Unbuzzd Wellness Inc., a licensee of Quantum BioPharma Ltd. (NASDAQ: QNTM), appointed Richard Buzbuzian as chief executive officer to lead the nationwide commercialization of its hangover remedy beverage, according to a company statement.

The appointment marks a shift in leadership as John Duffy transitions from CEO to product consultant. Buzbuzian will oversee the company's planned expansion into South Florida and Texas markets and pursue a stock exchange listing for Unbuzzd Wellness.

The company's unbuzzd product is a powder stick beverage that claims to accelerate alcohol metabolism and reduce hangover symptoms. A clinical study on the product was published in the World Journal of Pharmaceutical and Medical Research in 2026.

Unbuzzd Wellness plans to distribute through multiple channels including pharmacies, liquor stores, supermarkets, convenience stores and college stores. The functional beverage market is projected to reach $198 billion in 2026 with a 10.79% compound annual growth rate, according to the statement.

"The total addressable market for unbuzzd is substantial, creating an exciting commercial opportunity that begins with our nationwide rollout in the United States," Buzbuzian said in the statement.

Quantum BioPharma retains a 19.84% ownership stake in Unbuzzd Wellness as of December 31, 2025, and receives 7% royalties on sales until payments reach $250 million, after which royalties drop to 3%.

The product is currently available in 3-pack, 8-pack and 18-pack formats through the company's website. Unbuzzd Wellness operates as a non-trading but fully reporting public company.

You May Also Be Interested In

• Summit Hotel Properties CFO to depart June 15 for personal reasons
• Guaranteed Rate Affinity names Charity Moreland VP of national builder unit
• Compass Diversified CEO Elias Sabo to retire at year end